Literature DB >> 3940432

A population-based study of hemolytic-uremic syndrome in Oregon, 1979-1982.

M F Rogers, G W Rutherford, S R Alexander, J H DiLiberti, L Foster, L B Schonberger, E S Hurwitz.   

Abstract

The authors conducted a retrospective hospital-based chart review of cases of hemolytic-uremic syndrome among children less than or equal to 18 years of age, hospitalized in Oregon during the four-year period from January 1979 to December 1982. Thirty children with hemolytic-uremic syndrome living in Oregon were hospitalized during this period, for an average annual incidence of 0.97 cases per 100,000 children. Seventy per cent of cases occurred in children under five years of age, for an incidence of 2.65 cases per 100,000 children. Twenty-seven (90%) of the 30 children were white, and 17 (57%) were female. Twenty-four (80%) had a diarrheal prodromal illness including 20 who had bloody diarrhea. Twelve children (40%) acutely required peritoneal dialysis, and two (7%) developed chronic renal failure. Three children died, for a case fatality ratio of 10%. Sixty per cent of the 30 cases occurred during the summer and early fall months. Geographic clustering was also evident. Hemolytic-uremic syndrome is a rare but endemic disease in Oregon and may occur in small clusters. Although descriptions of several large series of patients have been published, this study describes the first statewide population-based study of this syndrome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940432     DOI: 10.1093/oxfordjournals.aje.a114207

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  13 in total

1.  Diarrhea-associated hemolytic uremic syndrome in southern Alberta: A long-term single-centre experience.

Authors:  Silviu Grisaru; Julian P Midgley; Lorraine A Hamiwka; Andrew W Wade; Susan M Samuel
Journal:  Paediatr Child Health       Date:  2011-06       Impact factor: 2.253

2.  Characteristics of children with sporadic hemolytic uremic syndrome in a single Northern California center.

Authors:  Gia Oh; Keith K Lau
Journal:  Int Urol Nephrol       Date:  2011-11-25       Impact factor: 2.370

3.  Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects.

Authors:  D V Milford; C M Taylor; B Guttridge; S M Hall; B Rowe; H Kleanthous
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

Review 4.  Haemolytic uraemic syndrome.

Authors:  W L Robson
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.022

5.  Haemolytic-uraemic syndrome in childhood: surveillance and case-control studies in Italy. Italian HUS Study Group.

Authors:  A Gianviti; F Rosmini; A Caprioli; R Corona; M C Matteucci; F Principato; I Luzzi; G Rizzoni
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

6.  A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators.

Authors:  P C Rowe; E Orrbine; H Lior; G A Wells; P N McLaine
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451

7.  Hemolytic-uremic syndrome: a population-based study in Washington, DC and Baltimore, Maryland.

Authors:  J S Kinney; T P Gross; C C Porter; M F Rogers; L B Schonberger; E S Hurwitz
Journal:  Am J Public Health       Date:  1988-01       Impact factor: 9.308

Review 8.  Racial incidence of hemolytic uremic syndrome.

Authors:  S M Jernigan; F B Waldo
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

9.  Sequelae of haemolytic uraemic syndrome.

Authors:  A Schlieper; P C Rowe; E Orrbine; M Zoubek; W Clark; N Wolfish; P N McLaine
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

Review 10.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.